疼痛パッチ市場- 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、流通チャネル別、地域別、競争別、2020～2030年

世界の疼痛パッチ市場は2024年に51億2,000万米ドルと評価され、予測期間中のCAGRは4.76%で2030年には67億8,000万米ドルに達すると予測されています。

疼痛パッチは、様々な形態の疼痛を管理するための便利で効果的なソリューションとして登場し、従来の経口薬に代わるものを提供しています。これらのパッチは経皮ドラッグデリバリーシステムを通じて局所的な緩和をもたらし、疼痛管理に快適さと利便性を求める個人にとって魅力的な選択肢となっています。世界の疼痛パッチ市場は、慢性疼痛疾患の増加、人口の高齢化、非侵襲的疼痛管理ソリューションに対する需要の高まりなどの要因により、近年大きな成長を遂げています。関節炎、腰痛、神経障害性疼痛、線維筋痛症などの慢性疼痛状態は世界的に増加傾向にあります。疼痛パッチは、経口薬に伴う副作用なしに慢性疼痛を管理するための的を絞ったアプローチを提供し、その人気の一因となっています。世界人口の高齢化に伴い、加齢に関連した疼痛症状の発生率も高くなっています。高齢者は、貼付が簡単で、頻繁な投薬の必要なく持続的な緩和が得られるペインパッチを好むことが多いです。疼痛パッチは非侵襲的であり、注射や錠剤を必要とせずに痛みを管理する目立たない方法を記載しています。これは、痛みを和らげるによる方法を探している患者にとって魅力的です。ドラッグデリバリー技術の継続的な研究開発により、より効率的で長持ちする製剤が開発されています。これらのパッチは現在、オピオイド、非ステロイド性抗炎症薬（NSAIDs）、筋弛緩薬など、さまざまな薬剤を送達することができます。製薬会社や医療機器メーカーは、疼痛パッチ製品ポートフォリオを継続的に拡大しています。これには、特定の痛みのタイプに対応するパッチの開発や、患者のニーズに基づいてドラッグデリバリーをモニタリング・調整するスマートパッチなどの革新的な機能の導入が含まれます。

市場促進要因

慢性疼痛の有病率の上昇が世界の疼痛パッチ市場を牽引

主要市場課題

価格設定と償還

主要市場動向

技術の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の疼痛パッチ市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別（非オピオイドパッチ、オピオイドパッチ）
  • タイプ別（処方薬、市販薬）
  • 流通チャネル別（病院薬局、ドラッグストアと小売薬局、オンラインプロバイダー）
  • 地域別
  • 企業別（2024年）
• 市場マップ

第6章 北米の疼痛パッチ市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の疼痛パッチ市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋の疼痛パッチ市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の疼痛パッチ市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの疼痛パッチ市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収（該当する場合）
• 製品の発売（該当する場合）

第13章 ポーターのファイブフォース分析

• 産業内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• NEXGEL Inc.
• Viatris Inc.
• Johnson and Johnson
• Teva Pharmaceutical Industries Ltd.
• Sorrento Therapeutics Inc.
• Hisamitsu Pharmaceutical Co., Inc.
• Endo, Inc.
• Purdue Pharma L.P.
• Amneal Pharmaceuticals LLC
• Grunenthal GmbH

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Pain Patch Market was valued at USD 5.12 Billion in 2024 and is expected to reach USD 6.78 Billion by 2030 with a CAGR of 4.76% during the forecast period. Pain patches have emerged as a convenient and effective solution for managing various forms of pain, offering an alternative to traditional oral medications. These patches deliver localized relief through transdermal drug delivery systems, making them an attractive option for individuals seeking comfort and convenience in pain management. The global pain patch market has experienced substantial growth in recent years, driven by factors such as the increasing prevalence of chronic pain conditions, an aging population, and a growing demand for non-invasive pain management solutions. Chronic pain conditions, such as arthritis, back pain, neuropathic pain, and fibromyalgia, are on the rise globally. Pain patches offer a targeted approach to manage chronic pain without the side effects associated with oral medications, contributing to their popularity. As the global population ages, there is a higher incidence of age-related pain conditions. Elderly individuals often prefer pain patches as they are easy to apply and provide sustained relief without the need for frequent dosing. Pain patches are non-invasive and offer a discreet way to manage pain without the need for injections or pills. This appeals to patients looking for alternative methods of pain relief. Ongoing research and development in drug delivery technologies have led to more efficient and long-lasting pain patch formulations. These patches can now deliver a variety of medications, including opioids, non-steroidal anti-inflammatory drugs (NSAIDs), and muscle relaxants. Pharmaceutical companies and medical device manufacturers are continuously expanding their pain patch product portfolios. This includes the development of patches for specific pain types and the introduction of innovative features such as smart patches that monitor and adjust drug delivery based on the patient's needs.

Key Market Drivers

Rising Prevalence of Chronic Pain is Driving the Global Pain Patch Market

Chronic pain is a widespread and debilitating condition that affects millions of people worldwide, significantly impacting their quality of life. As the global population continues to age and the incidence of chronic conditions such as arthritis, back pain, and neuropathy rises, the demand for effective pain management solutions is on the rise. One such solution that is gaining traction in the healthcare industry is the pain patch. These transdermal patches are becoming increasingly popular due to their convenience, effectiveness, and ability to provide consistent pain relief. According to Centers for Disease Control and Prevention, in 2021, approximately 20.9% of U.S. adults, equating to 51.6 million people, reported experiencing chronic pain. Of these, 6.9% (17.1 million individuals) experienced high-impact chronic pain, which significantly restricts daily activities. The prevalence of chronic pain was notably higher among non-Hispanic American Indian or Alaska Native

Key Market Challenges

Pricing and Reimbursement

The pricing of pain patches is a major challenge in the healthcare market, particularly in regions where there is a strong emphasis on cost containment and budget restrictions within public and private healthcare systems. Manufacturers of pain patches must navigate complex pricing structures while attempting to keep their products affordable for a wide range of patients. Reimbursement policies from insurance companies significantly influence the accessibility of pain patches to patients. If insurance plans do not cover certain treatments or if the reimbursement rates are low, patients may be less likely to afford these products, thereby limiting market reach. Additionally, the negotiation process between manufacturers and insurers can affect the final pricing, potentially influencing the uptake of pain patches in both institutional and consumer markets. Therefore, manufacturers are tasked with balancing product quality and affordability, which requires ongoing adaptation to changing market dynamics and reimbursement structures.

Key Market Trends

Technological Advancements

The global healthcare industry is witnessing a significant transformation, driven by rapid technological advancements and a growing emphasis on patient-centric solutions. One notable area where these changes are manifesting is in the pain management sector. Traditional methods of pain relief, such as oral medications, injections, and physical therapy, are now being complemented and, in some cases, replaced by innovative solutions like pain patches. These patches are gaining traction in the global market due to their convenience, effectiveness, and advancements in their technology. In January 2021, Hisamitsu Pharmaceutical Co., Inc. declared that it had received approval for modifying certain aspects of the previously approved specifications for their new transdermal analgesic anti-inflammatory patches, known as "Mohrus Paps XR 120 mg and 240 mg." This adjustment aimed to alleviate the irritation caused by the current additives.

Key Market Players

• NEXGEL Inc.
• Viatris Inc.
• Johnson and Johnson
• Teva Pharmaceutical Industries Ltd.
• Sorrento Therapeutics Inc.
• Hisamitsu Pharmaceutical Co., Inc.
• Endo, Inc.
• Purdue Pharma L.P.
• Amneal Pharmaceuticals LLC
• Grunenthal GmbH

Report Scope:

In this report, the Global Pain Patch Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pain Patch Market, By Product Type:

• Non-Opioid Patches
• Opioid Patches

Pain Patch Market, By Type:

• Prescription Medicines
• OTC Medicines

Pain Patch Market, By Distribution Channel:

• Hospital Pharmacies
• Drug Stores and Retail Pharmacies
• Online Providers

Pain Patch Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Pain Patch Market.

Available Customizations:

Global Pain Patch market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pain Patch Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Non-Opioid Patches, Opioid Patches)
  • 5.2.2. By Type (Prescription Medicines, OTC Medicines)
  • 5.2.3. By Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Pain Patch Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Type
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pain Patch Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Pain Patch Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Pain Patch Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Distribution Channel

7. Europe Pain Patch Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Type
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Pain Patch Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. United Kingdom Pain Patch Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. Italy Pain Patch Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. France Pain Patch Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Pain Patch Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Pain Patch Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Type
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Pain Patch Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Pain Patch Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Pain Patch Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Pain Patch Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Pain Patch Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Distribution Channel

9. South America Pain Patch Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Type
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Pain Patch Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. Argentina Pain Patch Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. Colombia Pain Patch Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Pain Patch Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Type
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Pain Patch Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Saudi Arabia Pain Patch Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. UAE Pain Patch Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. NEXGEL Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Viatris Inc.
• 14.3. Johnson and Johnson
• 14.4. Teva Pharmaceutical Industries Ltd.
• 14.5. Sorrento Therapeutics Inc.
• 14.6. Hisamitsu Pharmaceutical Co., Inc.
• 14.7. Endo, Inc.
• 14.8. Purdue Pharma L.P.
• 14.9. Amneal Pharmaceuticals LLC
• 14.10. Grunenthal GmbH

15. Strategic Recommendations

16. About Us & Disclaimer